Reducing residual thrombotic risk in patients with peripheral artery disease: Impact of the COMPASS trial

  1. Hernández, J.L.
  2. Lozano, F.S.
  3. Riambau, V.
  4. Almendro-Delia, M.
  5. Cosín-Sales, J.
  6. Bellmunt-Montoya, S.
  7. Garcia-Alegria, J.
  8. Garcia-Moll, X.
  9. Gomez-Doblas, J.J.
  10. Gonzalez-Juanatey, J.R.
  11. Fernández, C.S.
Journal:
Drugs in Context

ISSN: 1740-4398,  1745-1981

Year of publication: 2020

Volume: 9

Type: Review

DOI: 10.7573/DIC.2020-5-5 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus